p53-dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells
Data up to Jan 2025
Total Citations Per Year
Abstract
References (57)
WAF1, a potential mediator of p53 tumor suppression
1993 • 8,360 citations
p53 Mutations in Human Cancers
1991 • 8,133 citations
p53, the Cellular Gatekeeper for Growth and Division
1997 • 7,621 citations
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
1980 • 4,591 citations
The p53 tumour suppressor gene
1991 • 3,871 citations
p53: puzzle and paradigm.
1996 • 2,363 citations
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
1994 • 2,025 citations
The p53-mdm-2 autoregulatory feedback loop.
1993 • 1,795 citations
Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression Screen
1994 • 1,368 citations
Radiation-induced cell cycle arrest compromised by p21 deficiency
1995 • 1,249 citations
p21 is necessary for the p53-mediated G1 arrest in human cancer cells.
1995 • 1,193 citations
DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.
1994 • 1,165 citations
Cisplatin
1984 • 942 citations
Testicular Germ-Cell Cancer
1997 • 895 citations
Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.
1997 • 872 citations
DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2
1994 • 671 citations
Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis
1996 • 654 citations
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.
1994 • 646 citations
Cisplatin and DNA repair in cancer chemotherapy
1995 • 506 citations
Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells.
1981 • 491 citations
Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
1995 • 491 citations
Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene.
1994 • 465 citations
Cyclin G is a transcriptional target of the p53 tumor suppressor protein.
1994 • 450 citations
Activation of programmed cell death by anticancer agents: cisplatin as a model system.
1990 • 408 citations
Cell-cycle arrest versus cell death in cancer therapy
1997 • 394 citations
Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
1996 • 382 citations
Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53.
1983 • 313 citations
Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.
1996 • 298 citations
Negative feedback regulation of wild-type p53 biosynthesis.
1995 • 281 citations
A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.
1996 • 277 citations
Expression of the proto-oncogene int-1 is restricted to postmeiotic male germ cells and the neural tube of mid-gestational embryos
1987 • 261 citations
Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio.
1996 • 257 citations
Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells.
1988 • 226 citations
Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.
1996 • 218 citations
A functionally inactive p53 protein interatocarcinoma cells is activated by either DNA damage or cellular differentiation
1996 • 209 citations
Cancer therapy and p53
1995 • 194 citations
Post-Translational Regulation of the 54K Cellular Tumor Antigen in Normal and Transformed Cells
1981 • 177 citations
p53-independent apoptosis induced by paclitaxel through an indirect mechanism
1997 • 173 citations
The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells.
1994 • 145 citations
The role of apoptosis in cell killing by cisplatin: a flow cytometric study
1994 • 141 citations
Translational regulation of human p53 gene expression.
1996 • 139 citations
p53 Protein alterations in human testicular cancer including pre‐invasive intratubular germ‐cell neoplasia
1991 • 133 citations
Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma
1995 • 128 citations
Two Distinct Mechanisms Regulate the Levels of a Cellular Tumor Antigen, p53
1983 • 104 citations
The amino acid sequence of murine p53 determined from a c-DNA clone
1984 • 104 citations
Lack of correlation between cisplatin-induced apoptosis,p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines
1997 • 102 citations
Cisplatin resistance in human cancers
1991 • 96 citations
The p53 and mdm‐2 genes in human testicular germ‐cell tumors
1995 • 94 citations
Identification of p53 genetic suppressor elements which confer resistance to cisplatin
1997 • 81 citations
Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation.
1994 • 72 citations
DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status
1997 • 65 citations
A p53-independent pathway for induction of p21waf1cip1 and concomitant G1 arrest in UV-irradiated human skin fibroblasts.
1997 • 63 citations
p53 and translational control
1996 • 55 citations
Mutations of the p53 gene are not detectable in human testicular tumors.
1994 • 40 citations
Drug resistance: The clinical problem
1989 • 31 citations
p53 Gene Mutations in Chinese Human Testicular Seminoma
1993 • 29 citations
Characterization of protein kinase CK2 protein subunits and p53 in F9 teratocarcinoma cells in the absence and presence of cisplatin.
1994 • 1 citations
Cited By (0)
No citing papers found in database